Anna Sablina

Dr. Anna Sablina

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2005 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
ASAnna Sablina
Anna Sablina
ABAndrei V Budanov
Andrei V Budanov
GIGalina V Ilyinskaya
Galina V Ilyinskaya
LALarissa S Agapova
Larissa S Agapova
JKJulia E Kravchenko
Julia E Kravchenko
PCPeter Chumakov
Peter Chumakov

23 April 2004 in Science
Verified
Journal Article
Closed access
PDF file
ABAndrei V Budanov
Andrei V Budanov
ASAnna Sablina
Anna Sablina
EFElena Feinstein
Elena Feinstein
EKEugene V. Koonin
Eugene V. Koonin
PCPeter Chumakov
Peter Chumakov
Acting as a signal, hydrogen peroxide circumvents antioxidant defense by overoxidizing peroxiredoxins (Prxs), the enzymes that metabolize peroxides. We show that sestrins, a family of proteins whose expression is modulated by p53, are required for regeneration of Prxs containing Cys-SO 2 H, thus reestablishing the antioxidant firewall. Sestrins contain a predicted redox-active domain homologous to AhpD, the enzyme catalyzing the reduction of a bacterial Prx, AhpC. Purified Hi95 (sestrin 2) protein supports adenosine triphosphate–dependent reduction of overoxidized PrxI in vitro, indicating that unlike AhpD, which is a disulfide reductase, sestrins are cysteine sulfinyl reductases. As modulators of peroxide signaling and antioxidant defense, sestrins constitute potential therapeutic targets.

4 July 2016 in Nature Medicine
Verified
Journal Article
Closed access
CACarmen Adriaens
Carmen Adriaens
LSLaura Standaert
Laura Standaert
JBJasmine Barra
Jasmine Barra
MLMathilde Latil
Mathilde Latil
AVAnnelien Verfaillie
Annelien Verfaillie
JMJean-Christophe Marine
Jean-Christophe Marine

7 December 2018 in Science
Verified
Journal Article
Closed access
PDF file
MSM. Steklov
M. Steklov
SPS. Pandolfi
S. Pandolfi
Maria Francesca BaiettiMaria Francesca Baietti
Maria Francesca Baietti
ABA. Batiuk
A. Batiuk
PCP. Carai
P. Carai
ASAnna Sablina
Anna Sablina
Regulation of RAS by ubiquitination: The protein LZTR1 is mutated in human cancers and developmental diseases. Work from two groups now converges to implicate the protein in regulating signaling by the small guanosine triphosphatase RAS. Steklov et al. showed that mice haploinsufficient for LZTR1 recapitulated aspects of the human disease Noonan syndrome. Their biochemical studies showed that LZTR1 associated with RAS. LZTR1 appears to function as an adaptor that promotes ubiquitination of RAS, thus inhibiting its signaling functions. Bigenzahn et al. found LZTR1 in a screen for proteins whose absence led to resistance to the tyrosine kinase inhibitors used to treat cancers caused by the BCR-ABL oncogene product. Their biochemical studies and genetic studies in fruitflies also showed that loss of LZTR1 led to increased activity of RAS and signaling through the mitogen-activated protein kinase pathway. Science , this issue p. 1177 , p. 1171

1 May 2016 in Cancer Cell
Verified
Journal Article
Closed access
YCYanyan Cai
Yanyan Cai
JCJonathan Crowther
Jonathan Crowther
TPTibor Pastor
Tibor Pastor
LALayka Abbasi Asbagh
Layka Abbasi Asbagh
Maria Francesca BaiettiMaria Francesca Baietti
Maria Francesca Baietti
ASAnna Sablina
Anna Sablina

1 June 2007 in Cell
Verified
Journal Article
Closed access
ASAnna Sablina
Anna Sablina
WCWen Chen
Wen Chen
JAJason D. Arroyo
Jason D. Arroyo
LCLaura Corral
Laura Corral
MHMelissa Hector
Melissa Hector
WHWilliam C. Hahn
William C. Hahn